BAHRAIN’S health regulator has said it is working continuously to ensure that quality medicines are available at stable prices.
The National Health Regulatory Authority (NHRA) evaluates drug prices according to a specific published mechanism known to all pharmaceutical companies and agents, according to its chief executive Dr Mariam Al Jalahma .
&uuid=(email))